Decondensing cancer immunotherapy
Science · 2026
DOI: 10.1126/science.ael3828 ↗Kurz gefasst
Kommentar in der Zeitschrift Science, 2026. Verfasst von Arup K Chakraborty. Beteiligte Einrichtung: Departments of Chemical Engineering, Physics, and Chemistry, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Ca…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunotherapy, Neoplasms, T-Lymphocytes. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
A checkpoint inhibitor may switch off T cells in a surprising way
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Chemical Engineering, Physics, and Chemistry, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Ragon Institute of Massachusetts General Brigham, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Chakraborty, A. K. (2026). Decondensing cancer immunotherapy. Science. https://doi.org/10.1126/science.ael3828
Vancouver
Chakraborty AK. Decondensing cancer immunotherapy. Science. 2026. doi:10.1126/science.ael3828
BibTeX
@article{Chakraborty2026,
author = {Chakraborty, Arup K},
title = {Decondensing cancer immunotherapy},
journal = {Science},
year = {2026},
doi = {10.1126/science.ael3828}
}
EUVIMED